Effects of Escherichia Coli-derived Recombinant Human Bone Morphogenetic Protein-2 Loaded Porous Hydroxyaptite-based Ceramics on Calvarial Defect in Rabbits
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Recombinant human bone morphogenetic proteins (rhBMPs) have been widely used in regenerative therapies to promote bone formation. The production of rh- BMPs using bacterial systems such as Escherichia coli (E. coli) is estimated to facilitate clinical applications by lowering the cost without compromising biological activity. In clinical practice, rhBMP-2 and osteoconductive carriers (e.g., hydroxyapatite [HA] and bovine bone xenograft) are used together. This study examined the effect of E. coli-derived rhBMP-2 combined with porous HA-based ceramics on calvarial defect in rabbits. Methods: Six adult male New Zealand white rabbits were used in this study. The experimental groups were divided into the following 4 groups: untreated (NC), bovine bone graft (BO), porous HA (HA) and porous HA with rhBMP-2 (HA-BMP). Four transosseous defects of 8 mm in diameter were prepared using stainless steel trephine bur in the frontal and parietal bones. Histological and histomorphometric analyses at 4 weeks after surgery revealed significant new bone formation by porous HA alone. Results: HA-BMP showed significantly higher degree of bone formation compared with BO and HA group (P<0.05). The average new bone formation % (new bone area per total defect area) of NC, BO, HA, and HA-BMP at 4-week after surgery were 12.65±5.89%, 29.63±6.99%, 28.86±6.17% and 49.56±8.23%, respectively. However, there was no statistical difference in the bone formation between HA and BO groups. Conclusions: HA-BMP promoted more bone formation than NC, BO and HA alone. Thus, using E. coli-derived rhBMP-2 combined with porous HA-based ceramics can promote new bone formation.
Abstract
Background: Recombinant human bone morphogenetic proteins (rhBMPs) have been widely used in regenerative therapies to promote bone formation. The production of rh- BMPs using bacterial systems such as Escherichia coli (E. coli) is estimated to facilitate clinical applications by lowering the cost without compromising biological activity. In clinical practice, rhBMP-2 and osteoconductive carriers (e.g., hydroxyapatite [HA] and bovine bone xenograft) are used together. This study examined the effect of E. coli-derived rhBMP-2 combined with porous HA-based ceramics on calvarial defect in rabbits. Methods: Six adult male New Zealand white rabbits were used in this study. The experimental groups were divided into the following 4 groups: untreated (NC), bovine bone graft (BO), porous HA (HA) and porous HA with rhBMP-2 (HA-BMP). Four transosseous defects of 8 mm in diameter were prepared using stainless steel trephine bur in the frontal and parietal bones. Histological and histomorphometric analyses at 4 weeks after surgery revealed significant new bone formation by porous HA alone. Results: HA-BMP showed significantly higher degree of bone formation compared with BO and HA group (P<0.05). The average new bone formation % (new bone area per total defect area) of NC, BO, HA, and HA-BMP at 4-week after surgery were 12.65±5.89%, 29.63±6.99%, 28.86±6.17% and 49.56±8.23%, respectively. However, there was no statistical difference in the bone formation between HA and BO groups. Conclusions: HA-BMP promoted more bone formation than NC, BO and HA alone. Thus, using E. coli-derived rhBMP-2 combined with porous HA-based ceramics can promote new bone formation.
참고문헌 (26)
- Urist MR, "Bone: formation by autoinduction", Science, 150, pp.893~899 (1965)
- Reddi AH, "Initiation and promotion of bone differentiation by bone morphogenetic proteins", J Bone Miner Res, 8(Suppl 2), pp.S499~S502 (1993)
- Inoda H, "Histological investigation of osteoinductive properties of rh-BMP2 in a rat calvarial bone defect model", J Craniomaxillofac Surg, 32, pp.365~369 (2004)
- Hogan BL, "Bone morphogenetic proteins: multifunctional regulators of vertebrate development", Genes Dev, 10, pp.1580~1594 (1996)
- Sigurdsson TJ, "Periodontal repair in dogs: evaluation of rhBMP-2 carriers", Int J Periodontics Restorative Dent, 16, pp.524~537 (1996)
- Urist MR, "Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography", Proc Natl Acad Sci U S A, 81, pp.371~375 (1984)
- Israel DI, "Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells", Growth Factors, 7, pp.139~150 (1992)
- 이재협, "Expression, Purification and Osteogenic Bioactivity of Recombinant Human BMP-2 Derived by Escherichia Coli", 조직공학과 재생의학, 8(1), pp.8~15 (2011), 한국조직공학과 재생의학회
- Vallejo LF, "Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli", J Biotechnol, 94, pp.185~194 (2002)
- Lee J, "Comparative study of Chinese hamster ovary cell versus Escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model", J Periodontol, 84, pp.415~422 (2013)
- Geiger M, "Collagen sponges for bone regeneration with rhBMP-2", Adv Drug Deliv Rev, 55, pp.1613~1629 (2003)
- Daculsi G, "Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization", J Biomed Mater Res, 23, pp.883~894 (1989)
- Lee JH, "A prospective consecutive study of instrumented posterolateral lumbar fusion using synthetic hydroxyapatite (Bongros-HA) as a bone graft extender", J Biomed Mater Res A, 90, pp.804~810 (2009)
- Bignon A, "Effect of micro- and macroporosity of bone substitutes on their mechanical properties and cellular response", J Mater Sci Mater Med, 14, pp.1089~1097 (2003)
- Tsuruga E, "Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis", J Biochem, 121, pp.317~324 (1997)
- Ripamonti U, "Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates", Plast Reconstr Surg, 90, pp.382~393 (1992)
- Langer R, "Tissue engineering", Science, 260, pp.920~926 (1993)
- Murphy CM, "The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering", Biomaterials, 31, pp.461~466 (2010)
- Liebschner MA, "Biomechanical considerations of animal models used in tissue engineering of bone", Biomaterials, 25, pp.1697~1714 (2004)
- Jones JR, "Factors affecting the structure and properties of bioactive foam scaffolds for tissue engineering", J Biomed Mater Res B Appl Biomater, 68, pp.36~44 (2004)
- Vallet-Regí M, "Current trends on porous inorganic materials for biomedical applications", Chem Eng J, 137, pp.1~3 (2008)
- Karageorgiou V, "Porosity of 3D biomaterial scaffolds and osteogenesis", Biomaterials, 26, pp.5474~5491 (2005)
- Rohanizadeh R, "Hydroxyapatite as a carrier for bone morphogenetic protein", J Oral Implantol, 37, pp.659~672 (2011)
- Sciadini MF, "Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model", J Orthop Res, 18, pp.289~302 (2000)
- Park JC, "Dose- and time-dependent effects of recombinant human bone morphogenetic protein-2 on the osteogenic and adipogenic potentials of alveolar bone-derived stromal cells", J Periodontal Res, 47, pp.645~654 (2012)
- Yoshida K, "Enhancement by recombinant human bone morphogenetic protein-2 of bone formation by means of porous hydroxyapatite in mandibular bone defects", J Dent Res, 78, pp.1505~1510 (1999)